Inflammatory responses are the driving force of atherosclerosis development [20, 21], and many inflammatory pathways that contribute to atherogenesis are regulated by the transcription factor NF-κB, a master regulator of the innate and adaptive immune responses [22, 23, 21]. Here, NFKB1 is linked to atherosclerosis.